J2711 Injection neostigmin/glycopyrrolat
Also known as: neostigmine/glycopyrrolate, glyneostigmine combination
Injection of neostigmine combined with glycopyrrolate, a combination anticholinesterase and anticholinergic agent (Sugammadex alternative) for neuromuscular blockade reversal.
In Plain Language
muscle block reversal
Clinical Context
Used at end of general anesthesia to reverse neuromuscular blockade by acetylcholinesterase inhibition with vagolytic properties.
RVU Information
CPT J2711 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2711?
CPT J2711 (Injection neostigmin/glycopyrrolat) is a J Codes (Drugs) code. Injection of neostigmine combined with glycopyrrolate, a combination anticholinesterase and anticholinergic agent (Sugammadex alternative) for neuromuscular blockade reversal.
How is J2711 administered?
CPT J2711 is administered by a healthcare provider, typically via injection or infusion. Used at end of general anesthesia to reverse neuromuscular blockade by acetylcholinesterase inhibition with vagolytic properties. It is used by Anesthesiology.
When is CPT J2711 used?
Used at end of general anesthesia to reverse neuromuscular blockade by acetylcholinesterase inhibition with vagolytic properties.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.